Interleukin enhancer‐binding factor 2 promotes cell proliferation and DNA damage response in metastatic melanoma is a research paper published in Clinical and Translational Medicine (2021). On theSindex it has a DataRank of 0. It has been cited 26 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH HHS
Grant: S10 OD025017
National Institutes of Health
Grant: 1S10OD025017-01
Multiphoton Microscope for Deep Tissue Imaging
National Science Foundation
Grant: 0722519
MRI: Acquisition of a Stimulated Emission Depletion (STED) Microscope for Nanoscopic Resolution of Biological Samples
Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of MiR-181a targets STING to drive PARP inhibitor resistance in BRCA- mutated triple-negative breast cancer and ovarian cancer
Additional file 1 of MiR-181a targets STING to drive PARP inhibitor resistance in BRCA- mutated triple-negative breast cancer and ovarian cancer
Additional file 1 of Integrating trans-omics, cellular experiments and clinical validation to identify ILF2 as a diagnostic serum biomarker and therapeutic target in gastric cancer
Additional file 1 of Integrating trans-omics, cellular experiments and clinical validation to identify ILF2 as a diagnostic serum biomarker and therapeutic target in gastric cancer
Additional file 2 of MiR-181a targets STING to drive PARP inhibitor resistance in BRCA- mutated triple-negative breast cancer and ovarian cancer
Additional file 2 of MiR-181a targets STING to drive PARP inhibitor resistance in BRCA- mutated triple-negative breast cancer and ovarian cancer